EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C30H46N6O8 |
| Net Charge | 0 |
| Average Mass | 618.732 |
| Monoisotopic Mass | 618.33771 |
| SMILES | [H]/C(C(=O)OC([H])([H])C([H])([H])[H])=C(/[H])[C@@]([H])(N([H])C(=O)[C@@]([H])(N([H])C(=O)[C@@]([H])(N([H])C(=O)[C@@]([H])(N([H])C(=O)c1noc(C([H])([H])[H])c1[H])C([H])([H])[H])C([H])(C([H])([H])[H])C([H])([H])[H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])[H])C([H])([H])[C@@]1([H])C(=O)N([H])C([H])([H])C1([H])[H] |
| InChI | InChI=1S/C30H46N6O8/c1-8-43-24(37)10-9-21(15-20-11-12-31-27(20)39)33-28(40)22(13-16(2)3)34-30(42)25(17(4)5)35-26(38)19(7)32-29(41)23-14-18(6)44-36-23/h9-10,14,16-17,19-22,25H,8,11-13,15H2,1-7H3,(H,31,39)(H,32,41)(H,33,40)(H,34,42)(H,35,38)/b10-9+/t19-,20-,21+,22-,25-/m0/s1 |
| InChIKey | LIVSSCDUYUOZEL-GLXPMXKMSA-N |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| N-[(5-methylisoxazol-3-yl)carbonyl]-L-alanyl-L-valyl-N1-((1S)-4-ethoxy-4-oxo-1-{[(3S)-2-oxopyrrolidin-3-yl]methyl}but-2-enyl)-L-leucinamide (CHEBI:43193) is a isoxazoles (CHEBI:55373) |
| N-[(5-methylisoxazol-3-yl)carbonyl]-L-alanyl-L-valyl-N1-((1S)-4-ethoxy-4-oxo-1-{[(3S)-2-oxopyrrolidin-3-yl]methyl}but-2-enyl)-L-leucinamide (CHEBI:43193) is a pyrrolidin-2-ones (CHEBI:74223) |
| N-[(5-methylisoxazol-3-yl)carbonyl]-L-alanyl-L-valyl-N1-((1S)-4-ethoxy-4-oxo-1-{[(3S)-2-oxopyrrolidin-3-yl]methyl}but-2-enyl)-L-leucinamide (CHEBI:43193) is a tripeptide (CHEBI:47923) |
| Synonyms | Source |
|---|---|
| N-[(5-METHYLISOXAZOL-3-YL)CARBONYL]-L-ALANYL-L-VALYL-N~1~-((1S)-4-ETHOXY-4-OXO-1-{[(3S)-2-OXOPYRROLIDIN-3-YL]METHYL}BUT-2-ENYL)-L-LEUCINAMIDE | PDBeChem |
| N-[(5-methylisoxazol-3-yl)carbonyl]-L-alanyl-L-valyl-N-[(1S,2E)-4-ethoxy-4-oxo-1-{[(3S)-2-oxopyrrolidin-3-yl]methyl}but-2-en-1-yl]-L-leucinamide | PDBeChem |
| Manual Xrefs | Databases |
|---|---|
| I12 | PDBeChem |